Published online Jul 19, 2026. doi: 10.5498/wjp.117862
Revised: February 11, 2026
Accepted: March 25, 2026
Published online: July 19, 2026
Processing time: 157 Days and 1.6 Hours
Anxiety and depression are prevalent and often co-occurring mental health disorders. While mindfulness training has shown efficacy in reducing symptoms, the underlying mechanisms, particularly the role of psychological resilience, rem
To test whether mindfulness training eases anxiety and depression and whether resilience acts as a mediator.
In an 8 weeks study, 133 patients with anxiety/depression symptoms were ran
At baseline the groups did not differ on gender, age, illness duration or employment status (P > 0.05). Post-intervention, the observation group showed significantly greater improvement than the control group, with lower Hamilton Anxiety Rating Scale (20.88 ± 2.52 vs 25.95 ± 2.61) and Hamilton Depression Rating Scale scores (21.24 ± 1.65 vs 26.37 ± 1.94), and higher Five Facet Mindfulness Questionnaire (125.37 ± 12.72 vs 112.14 ± 12.05) and 10-item Connor-Davidson Resilience Scale scores (34.53 ± 2.87 vs 28.31 ± 4.13) (P < 0.001). Bootstrapped mediation analysis (5000 samples) indicated that psychological resilience significantly mediated the intervention’s benefits, accounting for 9.89% of anxiety reduction (indirect effect = -0.498, 95%CI: -1.045 to -0.010) and 18.97% of depression reduction (indirect effect = -1.002, 95%CI: -1.570 to -0.327).
Mindfulness therapy lessens anxiety and depression both on its own and by boosting resilience, offering a dual pathway that makes it a valuable add-on treatment for these disorders.
Core Tip: This randomized controlled trial demonstrates that mindfulness training not only directly alleviates symptoms of anxiety and depression, but also enhances patients’ psychological resilience, which in turn partially mediates symptom reduction. The findings reveal a dual-pathway mechanism, offering a clinically feasible and culturally adapted intervention model to accelerate recovery.